Essex Bio
Zhuhai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An ophthalmic-focused biopharma developing and commercializing biologics and small molecules for eye diseases.
Ophthalmology
Technology Platform
Integrated R&D platform for both biologic and small molecule drug discovery and development in ophthalmology.
Opportunities
Capitalizing on China's aging population and increasing diagnosis rates of chronic eye diseases.
Risk Factors
Pipeline dependency on a single therapeutic area and exposure to Chinese pharmaceutical pricing reforms.
Competitive Landscape
A well-established competitor in the Chinese ophthalmic market, facing competition from large MNCs and an increasing number of local biotechs.